Severe drug-induced thrombocytopenia after treatment with trastuzumab but not with lapatinib

Ann Oncol. 2009 Sep;20(9):1606-1607. doi: 10.1093/annonc/mdp370. Epub 2009 Jul 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / adverse effects*
  • Biomarkers, Tumor / analysis
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Capecitabine
  • Carcinoembryonic Antigen / drug effects
  • Carcinoembryonic Antigen / metabolism
  • Carcinoma, Ductal, Breast / drug therapy*
  • Carcinoma, Ductal, Breast / pathology
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Female
  • Fluorouracil / administration & dosage
  • Fluorouracil / analogs & derivatives
  • Humans
  • Immunohistochemistry
  • Lapatinib
  • Middle Aged
  • Mucin-1 / drug effects
  • Mucin-1 / metabolism
  • Quinazolines / therapeutic use*
  • Receptor, ErbB-2 / biosynthesis
  • Thrombocytopenia / chemically induced*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Carcinoembryonic Antigen
  • Mucin-1
  • Quinazolines
  • Lapatinib
  • Deoxycytidine
  • Capecitabine
  • Receptor, ErbB-2
  • Trastuzumab
  • Fluorouracil